First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

NCT07505043 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Hyperlipidemia, Hypertriglyceridemia

Interventions

DRUG: ISH0688 for injection
DRUG: Placebo

Sponsor

SUNHO（China）BioPharmaceutical CO., Ltd.